| Primary |
| Hypertension |
49.2% |
| Product Used For Unknown Indication |
20.6% |
| Poisoning Deliberate |
4.8% |
| Pain |
4.0% |
| Computerised Tomogram |
3.2% |
| Blood Pressure High |
2.4% |
| Constipation |
1.6% |
| Depression |
1.6% |
| Incontinence |
1.6% |
| Ischaemic Heart Disease Prophylaxis |
1.6% |
| Osteoporosis |
1.6% |
| Prophylaxis |
1.6% |
| Blood Pressure |
0.8% |
| Cardiac Failure Congestive |
0.8% |
| Dyspnoea |
0.8% |
| Liver Injury |
0.8% |
| Maternal Exposure Timing Unspecified |
0.8% |
| Prophylaxis Urinary Tract Infection |
0.8% |
| Proteinuria |
0.8% |
| Pulmonary Arterial Hypertension |
0.8% |
|
| Product Substitution Issue |
20.0% |
| Swollen Tongue |
12.7% |
| Pharmaceutical Product Complaint |
9.1% |
| Therapeutic Response Unexpected With Drug Substitution |
9.1% |
| Angioedema |
5.5% |
| Dyspnoea |
3.6% |
| Lip Swelling |
3.6% |
| Oligohydramnios |
3.6% |
| Product Quality Issue |
3.6% |
| Prostatic Specific Antigen Increased |
3.6% |
| Rash |
3.6% |
| Rash Erythematous |
3.6% |
| Respiratory Distress |
3.6% |
| Rhabdomyolysis |
3.6% |
| Anaphylactic Reaction |
1.8% |
| Atrioventricular Block Complete |
1.8% |
| Blood Pressure Decreased |
1.8% |
| Blood Pressure Diastolic Increased |
1.8% |
| Chills |
1.8% |
| Convulsion |
1.8% |
|
| Secondary |
| Hypertension |
34.3% |
| Product Used For Unknown Indication |
10.1% |
| Nephrotic Syndrome |
9.8% |
| Drug Use For Unknown Indication |
8.4% |
| Poisoning Deliberate |
5.2% |
| Pain |
4.6% |
| Blood Pressure Abnormal |
3.5% |
| Completed Suicide |
3.2% |
| Blood Pressure |
2.9% |
| Blood Calcium Decreased |
2.3% |
| Prostatic Disorder |
2.0% |
| Type 2 Diabetes Mellitus |
2.0% |
| Coronary Artery Disease |
1.7% |
| Suicide Attempt |
1.7% |
| Constipation |
1.4% |
| Depression |
1.4% |
| Hiv Infection |
1.4% |
| Intentional Overdose |
1.4% |
| Ischaemic Heart Disease Prophylaxis |
1.4% |
| Antiphospholipid Antibodies |
1.2% |
|
| Bartter's Syndrome |
14.0% |
| Hyperkalaemia |
7.0% |
| Subileus |
7.0% |
| Completed Suicide |
5.3% |
| Death |
5.3% |
| Drug Toxicity |
5.3% |
| Renal Failure Acute |
5.3% |
| Respiratory Arrest |
5.3% |
| Swollen Tongue |
5.3% |
| Vomiting |
5.3% |
| Atrial Fibrillation |
3.5% |
| Atrioventricular Block Complete |
3.5% |
| Drug Interaction |
3.5% |
| Electrocardiogram Qrs Complex Prolonged |
3.5% |
| Nausea |
3.5% |
| Oedema |
3.5% |
| Oedema Peripheral |
3.5% |
| Product Substitution Issue |
3.5% |
| Renal Tubular Necrosis |
3.5% |
| Toxicity To Various Agents |
3.5% |
|
| Concomitant |
| Product Used For Unknown Indication |
30.2% |
| Drug Use For Unknown Indication |
17.2% |
| Hypertension |
14.7% |
| Diabetes Mellitus |
5.8% |
| Blood Cholesterol Increased |
4.2% |
| Atrial Fibrillation |
3.2% |
| Type 2 Diabetes Mellitus |
3.1% |
| Rheumatoid Arthritis |
3.0% |
| Pain |
2.3% |
| Blood Pressure |
2.1% |
| Cardiac Disorder |
1.8% |
| Depression |
1.8% |
| Prophylaxis |
1.6% |
| Chronic Obstructive Pulmonary Disease |
1.4% |
| Smoking Cessation Therapy |
1.4% |
| Back Pain |
1.4% |
| Gastrooesophageal Reflux Disease |
1.2% |
| Osteoporosis |
1.2% |
| Blood Cholesterol |
1.2% |
| Asthma |
1.1% |
|
| Weight Decreased |
11.9% |
| Vomiting |
10.7% |
| Flushing |
7.3% |
| Weight Increased |
7.1% |
| Nausea |
5.7% |
| Drug Ineffective |
5.5% |
| Pain |
5.3% |
| Pruritus |
4.8% |
| Somnolence |
4.3% |
| Rash |
4.1% |
| Renal Failure Acute |
4.1% |
| Myocardial Infarction |
3.9% |
| Dyspnoea |
3.7% |
| Pain In Extremity |
3.6% |
| Death |
3.4% |
| Swelling Face |
3.2% |
| Oedema Peripheral |
3.0% |
| Diarrhoea |
2.8% |
| Paraesthesia |
2.8% |
| Ventricular Tachycardia |
2.7% |
|
| Interacting |
| Drug Use For Unknown Indication |
100.0% |
|
| Drug Interaction |
66.7% |
| Mania |
33.3% |
|
